(NYSE: BSX) shares tumbled before hours today despite fourth-quarter results that topped the consensus forecast.
Pulsed field ablation has fueled strong sales growth for the firm’s electrophysiology business over the past two years.
Boston Scientific (NYSE:BSX) outlined strong 2025 results and issued guidance for continued growth in 2026, highlighting ...
Boston Scientific Corporation (NYSE:BSX) is included among 13 Best Long Term Low Risk Stocks to Buy Now. On February 5, ...
Boston Scientific (NYSE:BSX) traded higher on Wednesday after the MedTech giant exceeded Street forecasts with its Q3 2025 results and boosted its full-year outlook following better-than-expected ...
Good morning, and welcome to the Boston Scientific Fourth Quarter 2024 Earnings Call. All participants will be listen-only mode. [Operator Instructions] Please note this event is being recorded. I ...
Boston Scientific Corporation (NYSE:BSX) Q4 2025 Earnings Call Transcript February 4, 2026 Boston Scientific Corporation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results